POZlife

POZLife: Life from the Infected and Effected point of veiw.

University of Alabama-Birmingham Joins New HIV Vaccine Initiative – The Body

Posted by pozlife on June 10, 2008

 

June 9, 2008

The National Institute of Allergy and Infectious Diseases has selected 10 research teams to work on a novel HIV vaccine approach.

The goal of the $15.6 million, five-year project is to attempt to neutralize HIV by activating white blood cells called B cells. In the immune system, B cells recognize antigens, a type of microbe, and produce antibodies that can lock onto antigens and flush them from the body. However, HIV can evade these B cells. Stimulating B cell production of protective antibodies to neutralize multiple HIV strains is believed to be a promising approach in the quest for an HIV vaccine.

Research centers involved in the project include the University of Alabama-Birmingham (UAB); Scripps Research Institute in La Jolla, Calif.; Vanderbilt University in Nashville; University of California-Irvine; University of Florida; Weill Cornell Medical College in New York City; University of Medicine and Dentistry of New Jersey in Newark; Uniformed Services University of the Health Sciences in Bethesda, Md.; University of Rochester; and the University of Colorado-Denver.

Dr. Harry W. Schroeder Jr. in the Division of Clinical Immunology and Rheumatology was awarded a $275,000 grant to helm the research at UA

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: